4//SEC Filing
ATOSSA GENETICS INC 4
Accession 0001144204-16-083012
$ATOSCIK 0001488039operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 3:04 PM ET
Size
5.4 KB
Accession
0001144204-16-083012
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorCEO10% Owner
Transactions
- Purchase
Common Stock
2016-02-16$0.53/sh+15,000$7,950→ 4,811,858 total(indirect: See Footnote)
Footnotes (2)
- [F1]Represents 15,000 shares purchased in an at-market transaction directly from Atossa Genetics, Inc.
- [F2]Consists of: (i) 4,333,315 shares of common stock owned by Ensisheim Partners, LLC ("Ensisheim"), and (ii) 478,543 shares of common stock owned directly by Dr. Quay. Shu-Chih Chen, Ph.D. and Dr. Quay share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Quay and Chen, and, as a result, Drs. Quay and Chen are deemed to be beneficial owners of the shares held by this entity.
Documents
Issuer
ATOSSA GENETICS INC
CIK 0001488039
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001488039
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 3:04 PM ET
- Size
- 5.4 KB